Prevention of Obesity and Insulin Resistance by Estrogens Requires ERα Activation Function-2 (ERαAF-2), Whereas ERαAF-1 Is Dispensable
The beneficial metabolic actions of estrogen-based therapies are mainly mediated by estrogen receptor α (ERα), a nuclear receptor that regulates gene transcription through two activation functions (AFs): AF-1 and AF-2. Using mouse models deleted electively for ERαAF-1 (ERαAF-1°) or ERαAF-2 (ERαAF-2°...
Main Authors: | Handgraaf, Sandra, Riant, Elodie, Fabre, Aurélie, Waget, Aurélie, Burcelin, Rémy, Lière, Philippe, Krust, Andrée, Chambon, Pierre, Arnal, Jean-François, Gourdy, Pierre |
---|---|
Format: | Online |
Language: | English |
Published: |
American Diabetes Association
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837069/ |
Similar Items
-
SERMs have substance-specific effects on bone, and these effects are mediated via ERαAF-1 in female mice
by: Börjesson, Anna E., et al.
Published: (2016) -
The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors
by: Chantalat, Elodie, et al.
Published: (2016) -
Bisphenol AF-Induced Endogenous Transcription Is Mediated by ERα and ERK1/2 Activation in Human Breast Cancer Cells
by: Li, Ming, et al.
Published: (2014) -
Human estrogen receptor-α (ER-α) transactivation by selective estrogen receptor modulators (SERMs) on VIT regulatory region in ER-α-negative breast cancer cell line Evsa-T transiently transfected by ER-α
by: Nyamagana Butera, IP, et al.
Published: (2001) -
Progression of Mouse Skin Carcinogenesis Is Associated with Increased Erα Levels and Is Repressed by a Dominant Negative Form of Erα
by: Logotheti, Stella, et al.
Published: (2012)